Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2113 - 2120 of 11617 results
A Wave of Organizations are Offering Paid Leave for Pregnancy Loss
March 10, 2022| News
Mintz To Give Leave For Miscarriages, Failed Surrogacy
March 10, 2022| News
Suppliers Out in Patent License Talks After Appeals Ruling
March 10, 2022| News
2021 Was a Good Year for The Lawyers
March 10, 2022| News
Avoid Unpaid Administrative Leave During Investigations
March 10, 2022| News
Famed Jewish Immigration Attorney Devotes Career to ‘Strangers in a Strange Land’
March 10, 2022| News
Chancery Asks If It's Right Venue For Biotech Stock Drop Suit
March 10, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.